[{"AccountsAndOtherReceivablesNetCurrent_0_Q2_USD":492000.0,"LinesOfCreditCurrent_0_Q2_USD":17961000.0,"LongTermDebt_0_Q2_USD":205676000.0,"LongTermDebtNoncurrent_0_Q2_USD":3970000.0,"LongTermInvestments_0_Q2_USD":8945000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-6927000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-9948000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":10584000.0,"NetIncomeLoss_1_Q2_USD":-16186000.0,"NetIncomeLoss_2_Q2_USD":14892000.0,"LineOfCreditFacilityMaximumBorrowingCapacity_0_Q2_USD":106257000.0,"NonoperatingIncomeExpense_1_Q2_USD":-16936000.0,"NumberOfReportableSegments_2_Q2_segment":2.0,"OperatingExpenses_1_Q2_USD":436837000.0,"OperatingExpenses_2_Q2_USD":943565000.0,"OperatingIncomeLoss_1_Q2_USD":5571000.0,"OperatingIncomeLoss_2_Q2_USD":44008000.0,"OperatingLeaseCost_2_Q2_USD":9100000.0,"OperatingLeaseLiability_0_Q2_USD":40707000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":10102000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":30605000.0,"NonoperatingIncomeExpense_2_Q2_USD":-23692000.0,"OperatingLeasePayments_2_Q2_USD":6484000.0,"LineOfCredit_0_Q2_USD":16197000.0,"LiabilitiesNoncurrent_0_Q2_USD":375085000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":1000000000.0,"InterestPaidNet_2_Q2_USD":4883000.0,"InventoryFinishedGoods_0_Q2_USD":38870000.0,"InventoryNet_0_Q2_USD":134722000.0,"InventoryRawMaterials_0_Q2_USD":6409000.0,"InventoryValuationReserves_0_Q2_USD":4844000.0,"InventoryWorkInProcess_0_Q2_USD":3449000.0,"InventoryWriteDown_1_Q2_USD":900000.0,"InventoryWriteDown_2_Q2_USD":3900000.0,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q2_USD":233000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":49045000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":3726000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":5700000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":7722000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":4535000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":8338000.0,"Liabilities_0_Q2_USD":679065000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":2421650000.0,"LiabilitiesCurrent_0_Q2_USD":303980000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":3474000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":10995000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":36349000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.057,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":69200000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":990190000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":18222000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":37537000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1466941000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":442408000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":987573000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":113236000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":225522000.0,"ShareBasedCompensation_2_Q2_USD":6107000.0,"RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1_Q2_USD":43000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":1742585000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2_Q2_USD":55275000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":467000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":159000.0,"Supplies_0_Q2_USD":14593000.0,"TreasuryStockShares_0_Q2_shares":8655082.0,"TreasuryStockValue_0_Q2_USD":1791000.0,"VariableLeaseCost_2_Q2_USD":1400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":644001280.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":646996891.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":55275000.0,"RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_2_Q2_USD":43000.0,"PurchaseObligation_0_Q2_USD":135500000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":600000.0,"OtherAssetsCurrent_0_Q2_USD":15877000.0,"OtherAssetsNoncurrent_0_Q2_USD":9600000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":3363000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-5707000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":3363000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-5707000.0,"OtherInventorySupplies_0_Q2_USD":90838000.0,"OtherLiabilitiesAndDeferredRevenueNoncurrent_0_Q2_USD":14798000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":24866000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-11783000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-12711000.0,"PaidInKindInterest_2_Q2_USD":4981000.0,"PaymentsToAcquireProductiveAssets_2_Q2_USD":18192000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":47627000.0,"PrepaidInsurance_0_Q2_USD":7374000.0,"ProceedsFromIssuanceOrSaleOfEquity_2_Q2_USD":466000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":982797000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":8079000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_2_Q2_USD":165000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_Q2_USD":106652000.0,"ProvisionForDoubtfulAccounts_1_Q2_USD":300000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":13904000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-1388000.0,"IncreaseDecreaseInInventories_2_Q2_USD":3817000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-7425000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":65757000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":65757000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-6454000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommonStockSharesAuthorized_0_Q2_shares":1000000000.0,"CommonStockSharesIssued_0_Q2_shares":689817971.0,"CommonStockValue_0_Q2_USD":6898000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-12823000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":9185000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":2987000.0,"ContractWithCustomerLiability_0_Q2_USD":8952000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":552000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":7425000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2_Q2_USD":28500000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":183198000.0,"DebtConversionConvertedInstrumentAmount1_2_Q2_USD":68775000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":2479000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":136416000.0,"Depreciation_1_Q2_USD":8000000.0,"Depreciation_2_Q2_USD":15400000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":8400000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":487000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":3474000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":-1059000.0,"AccountsPayableCurrent_0_Q2_USD":88512000.0,"AccountsReceivableGrossCurrent_0_Q2_USD":268327000.0,"AccountsReceivableNetCurrent_0_Q2_USD":265856000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":40899000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":187172000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":3347000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-9932000.0,"AdditionalPaidInCapital_0_Q2_USD":3214351000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3460000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":6107000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3500000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":6100000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":2471000.0,"AmortizationOfFinancingCosts_2_Q2_USD":424000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":12574000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":25151000.0,"Assets_0_Q2_USD":2421650000.0,"AssetsCurrent_0_Q2_USD":547029000.0,"AssetsFairValueDisclosure_0_Q2_USD":7892000.0,"AssetsHeldForSaleNotPartOfDisposalGroup_0_Q2_USD":33067000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":-103000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":20573000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":646996891.0,"DepreciationDepletionAndAmortization_2_Q2_USD":40561000.0,"EarningsPerShareBasic_2_Q2_USD":0.02,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":445515000.0,"GainLossOnDerivativeInstrumentsNetPretax_1_Q2_USD":-272000.0,"GainLossOnDerivativeInstrumentsNetPretax_2_Q2_USD":-711000.0,"GainLossOnDispositionOfAssets1_2_Q2_USD":3146000.0,"GainLossOnInvestments_1_Q2_USD":-67000.0,"GainLossOnInvestments_2_Q2_USD":-110000.0,"GainLossOnSaleOfInvestments_2_Q2_USD":1408000.0,"Goodwill_0_Q2_USD":677360000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-3242000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":378605000.0,"GoodwillImpairmentLoss_2_Q2_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":20316000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":-67000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":-110000.0,"IncomeTaxesPaidNet_2_Q2_USD":3690000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":4754000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":5314000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-11651000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-20352000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-49160000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-11365000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.053,"FinanceLeaseRightOfUseAsset_0_Q2_USD":4643000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":769000.0,"EarningsPerShareDiluted_2_Q2_USD":0.02,"EarningsPerShareDiluted_1_Q2_USD":-0.03,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-163000.0,"EquityMethodInvestmentQuotedMarketValue_0_Q2_USD":7100000.0,"EquityMethodInvestmentUnderlyingEquityInNetAssets_0_Q2_USD":2242000.0,"EquitySecuritiesFvNi_0_Q2_USD":7466000.0,"EquitySecuritiesFvNiRealizedGainLoss_2_Q2_USD":2981000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_2_Q2_USD":-1573000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q2_USD":35000.0,"FinanceLeaseInterestExpense_2_Q2_USD":1100000.0,"FinanceLeaseInterestPaymentOnLiability_2_Q2_USD":45000.0,"FinanceLeaseLiability_0_Q2_USD":4643000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":2084000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":2559000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":4891000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":1648000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":215000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":697000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1038000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1293000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":248000.0,"EarningsPerShareBasic_1_Q2_USD":-0.03,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":644001280.0,"Ticker":"OPK","CIK":"944809","name":"OPKO HEALTH, INC.","OfficialName":"OPKO Health Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2187471532.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20210729"}]